|
|
 |
|
| News Release |
|
|
Information in the news releases is current on the date of the announcement, but is subject to change without prior notice. |
| 1997 Release |
|
| December 18, 1997 | |
Notice of Subsidiary Merger
| |
| December 15, 1997 | |
Eisai Launches PARIET (sodium rabeprazole), A New Proton Pump Inhibitor for Peptic Ulcers in Japan
| |
| November 7, 1997 | |
Eisai Announces Completion of US Pharmaceutical Formulation Research and Manufacturing Facility
| |
| November 4, 1997 | |
Eisai Announces Non-Consolidated Semiannual Financial Results for the Fiscal Year Ending March 31, 1998
| |
| September 20, 1997 | |
Eisai Announces Launch of Consumer Health Information on Corporate Home Page
| |
| September 16, 1997 | |
Eisai Announces Launch of ARICEPT(R) (donepezil hydrochloride), NewTreatment For Alzheimer's Disease in Germany
| |
| September 4, 1997 | |
"KURTIME-MK", a Medicated Bath Additive Beneficial For Numerous Skin Disorders Including Eczema Launched By Eisai
| |
| August 25, 1997 | |
"SAHNE LIP", a Lip Balm For the Prevention of Dryness Launched By Eisai
| |
| August 22, 1997 | |
Eisai Establishes KAN Research Institute
| |
| July 28, 1997 | |
Eisai Establishes Operations in Korea
| |
| July 15, 1997 | |
Eisai's Alzheimer's Treatment Receives Agreement For Approval In 12 European Countries
| |
| June 11, 1997 | |
Eisai Machinery Division Receives ISO 9001 Certification
| |
| June 3, 1997 | |
Eisai Announces Ground Breaking For Pharmaceutical Production Facility in Suzhou, China
| |
| May 27, 1997 | |
Eisai Announces Non-Consolidated and Consolidated Financial Results for the Fiscal Year Ended March 31, 1997
| |
| April 15, 1997 | |
Eisai and Janssen Pharmaceutica Announce Strategic Alliance For New Proton Pump Inhibitor
| |
| April 14, 1997 | |
Eisai Announces Completion of US Process Research Facility
| |
| April 7, 1997 | |
Eisai Launches ARICEPT(TM) (donepezil hydrochloride), New Treatment For Alzheimer's Disease in the UK
| |
| March 5, 1997 | |
Eisai's New Alzheimer's Disease Treatment Was Filed In Mexico By Wyeth-Ayerst
| |
| February 26, 1997 | |
Notice of Dividend Payment for the Year Ending March 1997 (85th Fiscal Term)
| |
| February 27, 1997 | |
Eisai Launches ARICEPT(TM) (donepezil hydrochloride), New Treatment For Alzheimer's Disease In the US
| |
| February 26, 1997 | |
Eisai Receives Marketing Clearance In UK For ARICEPT(TM)(donepezil hydrochloride), A New Symptomatic Treatment For Alzheimer's Disease
| |
| January 22, 1997 | |
Eisai Submits Marketing Authorization Application (MAA) in U.K. for a New Proton Pump Inhibitor | |
| | | |
|
|
|
